A previous PET study examining mGluR1 availability within the cerebellum and frontal, parietal, and temporal cortices in early AD yielded no significant changes, however the hippocampus, which is one of the earliest brain regions to be affected, was not examined (Ishibashi et al., 2019). The gene discussed is GRM1; the disease is Alzheimer disease.